Diagnoses, outcomes, and chronicity predictors of patients with secondary immune thrombocytopenia: ten-year data from a hematology referral center
Rev. invest. clín
;
73(1): 31-38, Jan.-Feb. 2021. tab, graf
Article
in English
| LILACS
| ID: biblio-1289742
ABSTRACT
ABSTRACT Background:
Secondary immune thrombocytopenia (ITP) is a heterogeneous and unpredictable disease associated with various underlying conditions.Objective:
The objective of the study was to investigate clinical evolution and chronicity predictors in secondary ITP.Methods:
Patients treated at an academic medical center during 2008-2019 were stratified by age as children <16 years and adults >16 years. Responses to steroids, intravenous immunoglobulin G (IVIG), rituximab, and eltrombopag were classified as response (R) and complete response (CR). Risk factors for chronic ITP were determined by multiple regression with uni- and multi-variate analysis.Results:
Eighty-three patients were included, 37 children and 46 adults. The most frequent associated conditions were infections 53%, systemic lupus erythematosus (SLE) 24%, thyroid disease 9.6%, and Evans syndrome 3.6%. Response to first-line treatment in the whole cohort was 94%; CR 45.7%; and R 50.6%. Initial response to steroids alone was 91.3% (n = 21/23), rituximab plus high-dose dexamethasone (HDD) 93.3% (n = 14/15); children receiving IVIG alone 100% (n=12/12); and eltrombopag in adults 100% (n = 3/3). Relapse was documented in 19.4% of children and 34% of adults, at a median time of 15 and 2 months, respectively; 30.4% of adults (15.2% from the miscellaneous group, 10.9% SLE-associated, and 4.3% infection-associated) and 18.9% of children followed a chronic course; age ≥10 years and platelets ≥20 × 109/L were risk factors for chronic ITP in children.Conclusion:
Evolution was heterogeneous a better and more sustained response was documented in the infections group compared to SLE or the miscellaneous group. (REV INVEST CLIN. 2021;73(1)31-8)
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Purpura, Thrombocytopenic, Idiopathic
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
/
Risk factors
Limits:
Adolescent
/
Adult
/
Aged
/
Child
/
Child, preschool
/
Humans
/
Infant
Language:
English
Journal:
Rev. invest. clín
Journal subject:
Medicine
Year:
2021
Type:
Article
Affiliation country:
Mexico
Institution/Affiliation country:
Universidad Autónoma de Nuevo León/MX
Similar
MEDLINE
...
LILACS
LIS